Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disease model: Fanconi anemia.

Jasmine C Y Wong1, Manuel Buchwald

  • 1Program in Genetics and Genomics Biology, Research Institute, Dept of Molecular and Medical Genetics, The Hospital for Sick Children, University of Toronto, 555 University Ave, Toronto, Ontario, Canada.

Trends in Molecular Medicine
|March 7, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus.

Blood·2010
Same author

Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia.

The Journal of experimental medicine·2010
Same author

Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies.

Blood·2010
Same author

Basic research in paediatrics: Does it exist?

Paediatrics & child health·2009
Same author

In vivo potential effects of adenovirus type 5 E1A and E1B on lung carcinogenesis and lymphoproliferative inflammation.

Journal of virology·2008
Same author

Transgenic expression of CECR1 adenosine deaminase in mice results in abnormal development of heart and kidney.

Transgenic research·2005
Same journal

Hyocholic acids: Third bile acids for neonatal health.

Trends in molecular medicine·2026
Same journal

Clonal hematopoiesis in Alzheimer's brain: Protective, pathogenic, and context-dependent?

Trends in molecular medicine·2026
Same journal

Targeting amino acid metabolism in hepatocellular carcinoma.

Trends in molecular medicine·2026
Same journal

Turning perfusion into repair through ferroptosis blockade.

Trends in molecular medicine·2026
Same journal

CaMKK2: A tumor stress-integration node.

Trends in molecular medicine·2026
Same journal

Precision gene editing: From proof-of-concept to curative therapies.

Trends in molecular medicine·2026
See all related articles

Fanconi anemia (FA) mouse models exhibit hypersensitivity to DNA cross-linking agents, mimicking patient traits like reduced fertility. These models are crucial for understanding FA

Area of Science:

  • Genetics and Molecular Biology
  • Hematology
  • Cancer Research

Background:

  • Fanconi anemia (FA) is a rare genetic disorder characterized by bone marrow failure, congenital abnormalities, and a high risk of cancer.
  • FA is a chromosomal instability syndrome affecting DNA repair mechanisms.
  • Six genes linked to FA have been identified, and corresponding mouse models have been created.

Purpose of the Study:

  • To investigate the utility of Fanconi anemia mouse models in understanding the disease.
  • To characterize defects in FA hematopoietic cells and explore apoptotic pathways.
  • To evaluate the potential of these models for testing therapeutic strategies for FA.

Main Methods:

  • Generation of mice with targeted disruptions in Fanconi anemia genes.

Related Experiment Videos

  • Assessment of cellular hypersensitivity to DNA cross-linking agents.
  • Evaluation of hematological parameters, developmental abnormalities, and fertility in mouse models.

    • Main Results:

    • FA mouse models accurately replicate cellular hypersensitivity to DNA cross-linking agents, a hallmark of the disease.
    • While not spontaneously developing all FA features, these models exhibit reduced fertility, mirroring human patients.
    • Studies provide insights into the role of apoptosis in FA pathogenesis and defects in hematopoietic cells.

    Conclusions:

    • Fanconi anemia mouse models are valuable tools for elucidating FA disease mechanisms, including apoptotic pathway involvement.
    • These models offer a platform for characterizing FA hematopoietic cell defects.
    • Mouse models are instrumental in preclinical testing of novel treatments for Fanconi anemia.